How does Ultralife Corporation make mission-critical power and communications systems that customers trust?
Ultralife Corporation designs, manufactures, and sells high-reliability batteries, chargers, and communications gear for defense, medical, and industrial customers; its pivot into medical devices and industrial backups reduced defense revenue cyclicality and lifted margins in 2025 with revenue growth of 18%.

Focus on engineered, tested products and contracts with recurring spares and services; supply-chain integration and aftermarket sales drive predictable margin and cash conversion. See product detail: Ultralife SWOT Analysis
What Does Ultralife Actually Sell?
Ultralife Corporation sells specialized energy and communications hardware for extreme environments, focused on high-performance lithium batteries and military-grade RF and integration systems; customers get reliable, precision power and hardened communications for defense, medical, and industrial use.
Ultralife batteries and energy products center on rechargeable and non-rechargeable lithium chemistries, including HiRate and Thin Cell cells and custom battery packs for surgical robots, ventilators, and tactical radios.
OEMs in defense, medical device makers, and industrial equipment suppliers; governments and system integrators buy batteries and RF gear for mission-critical deployments. Read more on customer segments in Who Ultralife Company Serves.
Customers get long-life energy, high discharge (power) capability, and ruggedized communications hardware that maintain uptime in extreme temperatures and shock-critical for battlefield, clinical, and remote industrial use.
Ultralife company products are chosen for proven reliability, custom pack engineering, and compliance with military and medical standards; support and integrated system solutions reduce OEM development time and risk.
Fiscal 2025 sales split: the Battery and Energy Products segment generated $178,000,000 in revenue, while the Communications Systems segment fell to $13,100,000 from $20,400,000 in 2024, underscoring that Ultralife corporation's revenue mix is dominated by Ultralife batteries and related power solutions.
Ultralife SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Does Ultralife Run Day to Day?
Ultralife Corporation runs day-to-day as a vertically integrated manufacturer of batteries and power systems, combining automated cell production with custom engineering and global distribution to serve defense, medical, and industrial customers.
Ultralife company shifted from component integrator to vertical manufacturer after the October 2024 Electrochem acquisition, bringing cell manufacturing in-house to cut supplier risk and improve throughput.
Day-to-day, teams fulfill high-volume certified replacement batteries and bespoke Ultralife products, shipping via regional warehouses and global distributors for military, telecom, and medical customers.
Manufacturing runs across Newark, New York, and Abingdon, UK, blend high automation with strict quality control; R&D and new chemistries guide production choices, with R&D spend at roughly 3-5% of revenue.
Sales route through defense contracts, OEM agreements, authorized distributors, and online retail for Ultralife batteries; logistics teams manage global inventory and certified shipments.
Key assets include newly acquired Electrochem cell lines, Newark and Abingdon facilities, and AI-enabled battery management efforts; partnerships with defense OEMs and logistics providers keep supply chains intact.
Bringing cell production in-house and automating assembly lowers lead times, improves yield, and secures critical materials, so Ultralife corporation sustains defense-grade reliability and scales certified battery output.
Operations center on integrated cell manufacturing, high-complexity engineering, and a global distribution network, supported by continuous R&D and quality control across Newark, New York, and Abingdon.
- Core operating model: vertical manufacturing after October 2024 Electrochem acquisition
- Product delivery: certified replacement batteries and bespoke systems via distributors and direct contracts
- Main channel/support: in-house Electrochem cell lines, regional factories, and defense/OEM partnerships
- Efficiency driver: automation plus 3-5% of revenue invested in R&D and AI-enabled battery management
See strategic direction and context in this article: Where Ultralife Company Is Going
Ultralife PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
How Does Money Come In at Ultralife?
Ultralife company generates revenue from direct hardware sales of batteries and systems plus recurring replacement sales to a large installed base; the monetization logic mixes long-term defense contracts and consumable battery replacement cycles.
Ultralife corporation wins multi-year government and defense contracts for integrated power systems, which deliver large, lumpy orders and account for the bulk of system-level hardware sales.
Ultralife batteries are sold as certified replacements for medical and industrial devices, creating steady recurring revenue through frequent replacement cycles and regulatory certification lock-in.
Revenue mixes one-time hardware contract sales with recurring consumables; pricing reflects contract milestones for defense systems and per-unit pricing plus certification premiums for replacement batteries.
Repeat demand from an installed base-notably medical devices that produced about 28 percent of sales in early 2025-plus large defense contract wins drive revenue volatility and long-term visibility.
In fiscal 2025, total consolidated revenues were 191.2 million dollars, up 16.2 percent year-over-year; revenue comes from defense/system contracts and repeat consumable battery sales with high visibility from a year-end backlog of 110.2 million dollars (about 58 percent of trailing twelve-month sales).
- Direct hardware and integrated systems sales via long-term government and defense contracts
- Consumables model selling certified replacement Ultralife batteries for medical and industrial devices
- Mix of one-time contract revenue and per-unit replacement pricing with certification-driven premiums
- Installed base scale and medical segment mix (approx 28 percent of early-2025 sales) drive repeat demand and revenue visibility
See a company history and context in this article: History of Ultralife Company Explained
Ultralife SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Makes Ultralife's Model Strong or Fragile?
Ultralife company's model is strong because of high barriers to entry in battery manufacturing and its move toward vertical integration, but fragile due to customer concentration and raw-material sensitivity. Key strengths include supply-chain control and a diversified 2025 revenue mix; main vulnerabilities are one customer representing 27 percent of revenue and commodity price swings.
Vertical integration via Electrochem gives Ultralife corporation a structural cost edge and tighter quality control across battery manufacturing. High technical know-how and regulatory certifications for defense and medical use raise barriers to entry and protect margins.
Asset base includes manufacturing plants, proprietary cell designs, and IP in Ultralife technologies plus defense-qualified production lines; scale and diversified Ultralife products across telecom, medical robotics, and energy storage broaden addressable markets.
Model depends on a concentrated customer base (one customer = 27 percent of 2025 revenue) and stable access to lithium, nickel, and cobalt; disruptions or price spikes directly raise COGS and margin risk. Government contract cycles add timing volatility.
Durability appears cautiously positive: 2025 revenue split of 66.3 percent commercial and 33.7 percent government reduces federal dependence, and a large backlog slated to ship in 2026 supports revenue visibility. Still, exposure to raw-material volatility and potential government shutdowns leave the model exposed to external shocks.
Ultralife batteries work because manufacturing scale, vertical integration, and diversified end-markets create steady demand and margin improvement; the model breaks if key customers pull back or commodity costs spike.
- High technical and regulatory barrier to entry protects market position
- Electrochem vertical integration and proprietary cell tech are core capabilities
- Customer concentration (one client = 27 percent of 2025 revenue) is the primary constraint
- Model is cautiously resilient into 2026 but remains exposed to raw-material price swings and government spending cycles
For additional context on peers and competitive pressure, see Who Ultralife Company Competes With
Ultralife VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What Does Ultralife Company Stand For?
- How Did Ultralife Company Become What It Is Today?
- Who Owns Ultralife Company and Why Does It Matter?
- How Does Ultralife Company Sell Its Products and Services?
- Where Is Ultralife Company Going Next?
- Who Does Ultralife Company Serve?
- Who Does Ultralife Company Compete With?
Frequently Asked Questions
Ultralife sells specialized energy and communications hardware for extreme environments. Its main products are high-performance lithium batteries, custom battery packs, and military-grade RF and integration systems used by defense, medical, and industrial customers that need reliable power and hardened communications.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.